Rafael Meza, Ph.D. - Publications

Affiliations: 
2006 University of Washington, Seattle, Seattle, WA 
Area:
Mathematics, Biostatistics Biology, Oncology

160 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2024 Cook S, Buskiewicz J, Levy DT, Meza R, Fleischer NL. Association between cigar use, with and without cigarettes, and incident diagnosed COPD: a longitudinal cohort study. Respiratory Research. 25: 13. PMID 38178199 DOI: 10.1186/s12931-023-02649-2  0.338
2023 Kalousova L, Xie Y, Levy D, Meza R, Thrasher JF, Elliott MR, Titus AR, Fleischer NL. Cigarette Prices and Disparities in Cessation in the United States. Nicotine & Tobacco Research : Official Journal of the Society For Research On Nicotine and Tobacco. PMID 38127643 DOI: 10.1093/ntr/ntad254  0.345
2023 Meza R, Cao P, Jeon J, Warner KE, Levy DT. Trends in US Adult Smoking Prevalence, 2011 to 2022. Jama Health Forum. 4: e234213. PMID 38038988 DOI: 10.1001/jamahealthforum.2023.4213  0.613
2023 Knudsen AB, Trentham-Dietz A, Kim JJ, Mandelblatt JS, Meza R, Zauber AG, Castle PE, Feuer EJ. Estimated US Cancer Deaths Prevented With Increased Use of Lung, Colorectal, Breast, and Cervical Cancer Screening. Jama Network Open. 6: e2344698. PMID 37991759 DOI: 10.1001/jamanetworkopen.2023.44698  0.301
2023 Sánchez-Romero LM, Liber AC, Li Y, Yuan Z, Tam J, Travis N, Jeon J, Issabakhsh M, Meza R, Levy DT. The smoking and vaping model, A user-friendly model for examining the country-specific impact of nicotine VAPING product use: application to Germany. Bmc Public Health. 23: 2299. PMID 37990171 DOI: 10.1186/s12889-023-17152-y  0.567
2023 Skolnick S, Cao P, Jeon J, Meza R. Contribution of smoking, disease history, and survival to lung cancer disparities in Black individuals. Journal of the National Cancer Institute. Monographs. 2023: 204-211. PMID 37947334 DOI: 10.1093/jncimonographs/lgad016  0.626
2023 Meza R, Cao P, de Nijs K, Jeon J, Smith RA, Ten Haaf K, de Koning H. Assessing the impact of increasing lung screening eligibility by relaxing the maximum years-since-quit threshold. A simulation modeling study. Cancer. PMID 37909874 DOI: 10.1002/cncr.34925  0.605
2023 Brouwer AF, Jeon J, Jimenez-Mendoza E, Land SR, Holford TR, Friedman AS, Tam J, Mistry R, Levy DT, Meza R. Changing patterns of cigarette and ENDS transitions in the USA: a multistate transition analysis of adults in the PATH Study in 2017-2019 vs 2019-2021. Medrxiv : the Preprint Server For Health Sciences. PMID 37905028 DOI: 10.1101/2023.10.20.23297320  0.527
2023 Hong YR, Wheeler M, Wang R, Karanth S, Yoon HS, Meza R, Kaye F, Bian J, Jeon J, Gould MK, Braithwaite D. Patient-Provider Discussion About Lung Cancer Screening by Race and Ethnicity: Implications for Equitable Uptake of Lung Cancer Screening. Clinical Lung Cancer. PMID 37673782 DOI: 10.1016/j.cllc.2023.08.013  0.559
2023 Jeon J, Mok Y, Meza R. Cross-sectional Patterns and Longitudinal Transitions of Premium and Non-Premium Cigar Use in the United States. Nicotine & Tobacco Research : Official Journal of the Society For Research On Nicotine and Tobacco. 25: S16-S23. PMID 37506231 DOI: 10.1093/ntr/ntad031  0.442
2023 Issabakhsh M, Sánchez-Romero LM, Le TTT, Liber AC, Tan J, Li Y, Meza R, Mendez D, Levy DT. Machine learning application for predicting smoking cessation among US adults: An analysis of waves 1-3 of the PATH study. Plos One. 18: e0286883. PMID 37289765 DOI: 10.1371/journal.pone.0286883  0.336
2023 Le TTT, Issabakhsh M, Li Y, Sánchez-Romero LM, Tan J, Meza R, Levy D, Mendez D. Are the relevant risk factors being adequately captured in empirical studies of smoking initiation? A machine learning analysis based on the Population Assessment of Tobacco and Health study. Nicotine & Tobacco Research : Official Journal of the Society For Research On Nicotine and Tobacco. PMID 37099744 DOI: 10.1093/ntr/ntad066  0.326
2023 Shafie Khorassani F, Brouwer AF, Hirschtick JL, Jeon J, Jimenez-Mendoza E, Meza R, Fleischer NL. Patterns of poly tobacco use among adults in the Population Assessment of Tobacco and Health (PATH) study, 2013-2017: a multistate Markov transition analysis. Tobacco Control. PMID 37094934 DOI: 10.1136/tc-2022-057822  0.526
2023 Cook S, Hirschtick JL, Barnes G, Arenberg D, Bondarenko I, Patel A, Jiminez Mendoza E, Jeon J, Levy D, Meza R, Fleischer NL. Time-varying association between cigarette and ENDS use on incident hypertension among US adults: a prospective longitudinal study. Bmj Open. 13: e062297. PMID 37085311 DOI: 10.1136/bmjopen-2022-062297  0.504
2023 Brouwer AF, Jeon J, Jimenez-Mendoza E, Land SR, Holford TR, Friedman AS, Tam J, Mistry R, Levy DT, Meza R. Changing patterns of cigarette and ENDS transitions in the USA: a multistate transition analysis of youth and adults in the PATH Study in 2015-2017 vs 2017-2019. Tobacco Control. PMID 36977570 DOI: 10.1136/tc-2022-057905  0.5
2023 Phung MT, Pearce CL, Meza R, Jeon J. Trends of Ovarian Cancer Incidence by Histotype and Race/Ethnicity in the United States 1992-2019. Cancer Research Communications. 3: 1-8. PMID 36968229 DOI: 10.1158/2767-9764.CRC-22-0410  0.52
2023 Levy DT, Tam J, Jeon J, Holford TR, Fleischer NL, Meza R. Summary and Concluding Remarks: Patterns of Birth Cohort‒Specific Smoking Histories. American Journal of Preventive Medicine. 64: S72-S79. PMID 36935130 DOI: 10.1016/j.amepre.2022.12.007  0.618
2023 Cao P, Jeon J, Tam J, Fleischer NL, Levy DT, Holford TR, Meza R. Smoking Disparities by Level of Educational Attainment and Birth Cohort in the U.S. American Journal of Preventive Medicine. 64: S22-S31. PMID 36935129 DOI: 10.1016/j.amepre.2022.06.021  0.543
2023 Cook SF, Hirschtick JL, Fleischer NL, Arenberg DA, Barnes GD, Levy DT, Sanchez-Romero LM, Jeon J, Meza R. Cigarettes, ENDS Use, and Chronic Obstructive Pulmonary Disease Incidence: A Prospective Longitudinal Study. American Journal of Preventive Medicine. PMID 36890083 DOI: 10.1016/j.amepre.2023.01.038  0.521
2023 Tam J, Levy DT, Feuer EJ, Jeon J, Holford TR, Meza R. Using the Past to Understand the Future of U.S. and Global Smoking Disparities: A Birth Cohort Perspective. American Journal of Preventive Medicine. PMID 36781373 DOI: 10.1016/j.amepre.2022.12.003  0.57
2023 Tam J, Jaffri MA, Mok Y, Jeon J, Szklo AS, Souza MC, Holford TR, Levy DT, Cao P, Sánchez-Romero LM, Meza R. Patterns of Birth Cohort‒Specific Smoking Histories in Brazil. American Journal of Preventive Medicine. PMID 36775755 DOI: 10.1016/j.amepre.2022.12.002  0.587
2023 Jeon J, Inoue-Choi M, Mok Y, McNeel TS, Tam J, Freedman ND, Meza R. Mortality Relative Risks by Smoking, Race/Ethnicity, and Education. American Journal of Preventive Medicine. PMID 36775754 DOI: 10.1016/j.amepre.2022.12.006  0.555
2023 Toumazis I, Cao P, de Nijs K, Bastani M, Munshi V, Hemmati M, Ten Haaf K, Jeon J, Tammemägi M, Gazelle GS, Feuer EJ, Kong CY, Meza R, de Koning HJ, Plevritis SK, et al. Risk Model-Based Lung Cancer Screening : A Cost-Effectiveness Analysis. Annals of Internal Medicine. PMID 36745885 DOI: 10.7326/M22-2216  0.561
2023 Holford TR, McKay L, Jeon J, Tam J, Cao P, Fleischer NL, Levy DT, Meza R. Smoking Histories by State in the U.S. American Journal of Preventive Medicine. PMID 36653233 DOI: 10.1016/j.amepre.2022.08.018  0.574
2023 Meza R, Cao P, Jeon J, Fleischer NL, Holford TR, Levy DT, Tam J. Patterns of Birth Cohort‒Specific Smoking Histories by Race and Ethnicity in the U.S. American Journal of Preventive Medicine. PMID 36653232 DOI: 10.1016/j.amepre.2022.06.022  0.586
2023 Jeon J, Cao P, Fleischer NL, Levy DT, Holford TR, Meza R, Tam J. Birth Cohort‒Specific Smoking Patterns by Family Income in the U.S. American Journal of Preventive Medicine. PMID 36653231 DOI: 10.1016/j.amepre.2022.07.019  0.569
2022 Xi Q, Meza R, Leventhal A, Tam J. Modeling cigarette smoking disparities between people with and without serious psychological distress in the US, 1997-2100. Preventive Medicine. 166: 107385. PMID 36495925 DOI: 10.1016/j.ypmed.2022.107385  0.37
2022 Kim RY, Rendle KA, Mitra N, Saia CA, Neslund-Dudas C, Greenlee RT, Burnett-Hartman AN, Honda SA, Simoff MJ, Schapira MM, Croswell JM, Meza R, Ritzwoller DP, Vachani A. Socioeconomic Status as a Mediator of Racial Disparity in Annual Lung Cancer Screening Adherence. American Journal of Respiratory and Critical Care Medicine. PMID 36306485 DOI: 10.1164/rccm.202208-1590LE  0.31
2022 Levy DT, Cadham CJ, Li Y, Yuan Z, Liber AC, Oh H, Travis N, Issabakhsh M, Sweanor DT, Sánchez-Romero LM, Meza R, Cummings KM. A Decision-Theoretic Public Health Framework for Heated Tobacco and Nicotine Vaping Products. International Journal of Environmental Research and Public Health. 19. PMID 36294011 DOI: 10.3390/ijerph192013431  0.316
2022 Mok Y, Jeon J, Levy DT, Meza R. Associations between e-cigarette use and e-cigarette flavors with cigarette smoking quit attempts and quit success: Evidence from a US large, nationally representative 2018-2019 survey. Nicotine & Tobacco Research : Official Journal of the Society For Research On Nicotine and Tobacco. PMID 36250607 DOI: 10.1093/ntr/ntac241  0.563
2022 Cao P, Jeon J, Meza R. Evaluation of benefits and harms of adaptive screening schedules for lung cancer: A microsimulation study. Journal of Medical Screening. 9691413221118194. PMID 35989646 DOI: 10.1177/09691413221118194  0.569
2022 Hirschtick JL, Cook S, Patel A, Barnes GD, Arenberg D, Bondarenko I, Levy DT, Jeon J, Jimenez Mendoza E, Meza R, Fleischer NL. Longitudinal associations between exclusive and dual use of electronic nicotine delivery systems and cigarettes and self-reported incident diagnosed cardiovascular disease among adults. Nicotine & Tobacco Research : Official Journal of the Society For Research On Nicotine and Tobacco. PMID 35907264 DOI: 10.1093/ntr/ntac182  0.481
2022 Brouwer AF, Engle JM, Jeon J, Meza R. Sociodemographic survival disparities for lung cancer in the United States, 2000-2016. Journal of the National Cancer Institute. PMID 35866998 DOI: 10.1093/jnci/djac144  0.53
2022 Cao P, Smith L, Mandelblatt JS, Jeon J, Taylor KL, Zhao A, Levy DT, Williams RM, Meza R, Jayasekera J. Cost-Effectiveness of a Telephone-based Smoking Cessation Randomized Trial in the Lung Cancer Screening Setting. Jnci Cancer Spectrum. PMID 35818125 DOI: 10.1093/jncics/pkac048  0.604
2022 Taylor KL, Williams RM, Li T, Luta G, Smith L, Davis KM, Stanton C, Niaura R, Abrams D, Lobo T, Mandelblatt J, Jayasekera J, Meza R, Jeon J, Cao P, et al. A Randomized Trial of Telephone-Based Smoking Cessation Treatment in the Lung Cancer Screening Setting. Journal of the National Cancer Institute. PMID 35818122 DOI: 10.1093/jnci/djac127  0.613
2022 Meza R, Jeon J, Jimenez-Mendoza E, Mok Y, Cao P, Foley KL, Chiles C, Ostroff JS, Cinciripini PM, Minnix J, Rigotti NA, Haas JS, Taylor K, Williams RM, Toll BA, et al. National Cancer Institute Smoking Cessation at Lung Examination Trials Brief Report: Baseline Characteristics and Comparison With the U.S. General Population of Lung Cancer Screening-Eligible Patients. Jto Clinical and Research Reports. 3: 100352. PMID 35815319 DOI: 10.1016/j.jtocrr.2022.100352  0.641
2022 Braithwaite D, Karanth SD, Slatore CG, Zhang D, Bian J, Meza R, Jeon J, Tammemagi M, Schabath M, Wheeler M, Guo Y, Hochhegger B, Kaye FJ, Silvestri GA, Gould MK. Personalised Lung Cancer Screening (PLuS) study to assess the importance of coexisting chronic conditions to clinical practice and policy: protocol for a multicentre observational study. Bmj Open. 12: e064142. PMID 35732383 DOI: 10.1136/bmjopen-2022-064142  0.569
2022 Meza R, Jeon J. Mechanistic and biologically based models in epidemiology; a powerful underutilized tool. American Journal of Epidemiology. PMID 35650016 DOI: 10.1093/aje/kwac099  0.509
2022 Brouwer AF, Levy DT, Jeon J, Jimenez-Mendoza E, Sanchez-Romero LM, Mistry R, Meza R. The impact of current tobacco product use definitions on estimates of transitions between cigarette and ENDS use. Nicotine & Tobacco Research : Official Journal of the Society For Research On Nicotine and Tobacco. PMID 35589561 DOI: 10.1093/ntr/ntac132  0.477
2022 Zavala-Arciniega L, Hirschtick JL, Meza R, Fleischer NL. E-cigarette characteristics and cigarette smoking cessation behaviors among U.S. Adult dual users of cigarettes and e-cigarettes. Preventive Medicine Reports. 26: 101748. PMID 35256927 DOI: 10.1016/j.pmedr.2022.101748  0.311
2021 Tam J, Jeon J, Thrasher JF, Hammond D, Holford TR, Levy DT, Meza R. Estimated Prevalence of Smoking and Smoking-Attributable Mortality Associated With Graphic Health Warnings on Cigarette Packages in the US From 2022 to 2100. Jama Health Forum. 2: e212852. PMID 35977179 DOI: 10.1001/jamahealthforum.2021.2852  0.569
2021 Cook S, Hirschtick JL, Patel A, Brouwer A, Jeon J, Levy DT, Meza R, Fleischer NL. A longitudinal study of menthol cigarette use and smoking cessation among adult smokers in the US: Assessing the roles of racial disparities and E-cigarette use. Preventive Medicine. 154: 106882. PMID 34793851 DOI: 10.1016/j.ypmed.2021.106882  0.595
2021 Brouwer AF, Jeon J, Cook SF, Usidame B, Hirschtick JL, Jimenez-Mendoza E, Mistry R, Fleischer NL, Holford TR, Mendez D, Levy DT, Meza R. The Impact of Menthol Cigarette Flavor in the U.S.: Cigarette and ENDS Transitions by Sociodemographic Group. American Journal of Preventive Medicine. PMID 34740512 DOI: 10.1016/j.amepre.2021.08.007  0.568
2021 Toumazis I, de Nijs K, Cao P, Bastani M, Munshi V, Ten Haaf K, Jeon J, Gazelle GS, Feuer EJ, de Koning HJ, Meza R, Kong CY, Han SS, Plevritis SK. Cost-effectiveness Evaluation of the 2021 US Preventive Services Task Force Recommendation for Lung Cancer Screening. Jama Oncology. PMID 34673885 DOI: 10.1001/jamaoncol.2021.4942  0.573
2021 Meza R, Cao P, Jeon J, Taylor KL, Mandelblatt JS, Feuer EJ, Lowy DR. Brief Report: Impact of joint lung cancer screening and cessation interventions under the new USPSTF recommendations. Journal of Thoracic Oncology : Official Publication of the International Association For the Study of Lung Cancer. PMID 34648947 DOI: 10.1016/j.jtho.2021.09.011  0.567
2021 Ritzwoller DP, Meza R, Carroll NM, Blum-Barnett E, Burnett-Hartman AN, Greenlee RT, Honda SA, Neslund-Dudas C, Rendle KA, Vachani A. Evaluation of Population-Level Changes Associated With the 2021 US Preventive Services Task Force Lung Cancer Screening Recommendations in Community-Based Health Care Systems. Jama Network Open. 4: e2128176. PMID 34636916 DOI: 10.1001/jamanetworkopen.2021.28176  0.328
2021 Levy DT, Meza R, Yuan Z, Li Y, Cadham C, Sanchez-Romero LM, Travis N, Knoll M, Liber AC, Mistry R, Hirschtick JL, Fleischer NL, Skolnick S, Brouwer AF, Douglas C, et al. Public health impact of a US ban on menthol in cigarettes and cigars: a simulation study. Tobacco Control. PMID 34475258 DOI: 10.1136/tobaccocontrol-2021-056604  0.551
2021 Patel A, Hirschtick JL, Cook S, Usidame B, Mistry R, Levy DT, Meza R, Fleischer NL. Sociodemographic Patterns of Exclusive and Dual Use of ENDS and Menthol/Non-Menthol Cigarettes among US Youth (Ages 15-17) Using Two Nationally Representative Surveys (2013-2017). International Journal of Environmental Research and Public Health. 18. PMID 34360077 DOI: 10.3390/ijerph18157781  0.328
2021 Mistry R, Bondarenko I, Jeon J, Brouwer AF, Mattingly DT, Hirschtick JL, Jimenez-Mendoza E, Levy DT, Land SR, Elliott MR, Taylor JMG, Meza R, Fleischer NL. Latent class analysis of use frequencies for multiple tobacco products in US adults. Preventive Medicine. 106762. PMID 34358593 DOI: 10.1016/j.ypmed.2021.106762  0.472
2021 Sánchez-Romero LM, Cadham CJ, Hirschtick JL, Mattingly DT, Cho B, Fleischer NL, Brouwer A, Mistry R, Land SR, Jeon J, Meza R, Levy DT. A comparison of tobacco product prevalence by different frequency of use thresholds across three US surveys. Bmc Public Health. 21: 1203. PMID 34162379 DOI: 10.1186/s12889-021-11283-w  0.497
2021 Sánchez-Romero LM, Zavala-Arciniega L, Reynales-Shigematsu LM, de Miera-Juárez BS, Yuan Z, Li Y, Lau YK, Fleischer NL, Meza R, Thrasher JF, Levy DT. The Mexico SimSmoke tobacco control policy model: Development of a simulation model of daily and nondaily cigarette smoking. Plos One. 16: e0248215. PMID 34153063 DOI: 10.1371/journal.pone.0248215  0.33
2021 Levy DT, Sánchez-Romero LM, Travis N, Yuan Z, Li Y, Skolnick S, Jeon J, Tam J, Meza R. US Nicotine Vaping Product Simulation Model: The Effect of Vaping and Tobacco Control Policies on Smoking Prevalence and Smoking-Attributable Deaths. International Journal of Environmental Research and Public Health. 18. PMID 34063672 DOI: 10.3390/ijerph18094876  0.596
2021 Levy DT, Tam J, Sanchez-Romero LM, Li Y, Yuan Z, Jeon J, Meza R. Public health implications of vaping in the USA: the smoking and vaping simulation model. Population Health Metrics. 19: 19. PMID 33865410 DOI: 10.1186/s12963-021-00250-7  0.57
2021 Titus AR, Thrasher JF, Gamarel KE, Meza R, Fleischer NL. Smoke-free laws and disparities in secondhand smoke exposure among nonsmoking adults in the United States, 1999-2014. Nicotine & Tobacco Research : Official Journal of the Society For Research On Nicotine and Tobacco. PMID 33690865 DOI: 10.1093/ntr/ntab038  0.33
2021 Chang JT, Meza R, Levy DT, Arenberg D, Jeon J. Prediction of COPD risk accounting for time-varying smoking exposures. Plos One. 16: e0248535. PMID 33690706 DOI: 10.1371/journal.pone.0248535  0.568
2021 Meza R, Jeon J, Toumazis I, Ten Haaf K, Cao P, Bastani M, Han SS, Blom EF, Jonas DE, Feuer EJ, Plevritis SK, de Koning HJ, Kong CY. Evaluation of the Benefits and Harms of Lung Cancer Screening With Low-Dose Computed Tomography: Modeling Study for the US Preventive Services Task Force. Jama. 325: 988-997. PMID 33687469 DOI: 10.1001/jama.2021.1077  0.609
2021 Cadham CJ, Cao P, Jayasekera J, Taylor KL, Levy DT, Jeon J, Elkin E, Foley KL, Joseph A, Kong CY, Minnix JA, Rigotti NA, Toll BA, Zeliadt SB, Meza R, et al. Cost-Effectiveness of Smoking Cessation Interventions in the Lung Cancer Screening Setting: A Simulation Study. Journal of the National Cancer Institute. PMID 33484569 DOI: 10.1093/jnci/djab002  0.622
2020 Kalousova L, Levy D, Titus AR, Meza R, Thrasher JF, Elliott MR, Fleischer NL. Cigarette taxes, prices, and disparities in current smoking in the United States. Ssm - Population Health. 12: 100686. PMID 33241103 DOI: 10.1016/j.ssmph.2020.100686  0.323
2020 Brouwer AF, Jeon J, Hirschtick JL, Jimenez-Mendoza E, Mistry R, Bondarenko IV, Land SR, Holford TR, Levy DT, Taylor JMG, Fleischer NL, Meza R. Transitions between cigarette, ENDS and dual use in adults in the PATH study (waves 1-4): multistate transition modelling accounting for complex survey design. Tobacco Control. PMID 33199541 DOI: 10.1136/tobaccocontrol-2020-055967  0.483
2020 Hirschtick JL, Mattingly DT, Cho B, Arciniega LZ, Levy DT, Sanchez-Romero LM, Jeon J, Land SR, Mistry R, Meza R, Fleischer NL. Exclusive, Dual, and Polytobacco Use Among US Adults by Sociodemographic Factors: Results From 3 Nationally Representative Surveys. American Journal of Health Promotion : Ajhp. 890117120964065. PMID 33047619 DOI: 10.1177/0890117120964065  0.462
2020 Ten Haaf K, Jeon J, Tammemägi MC, Han SS, Kong CY, Plevritis SK, Feuer EJ, de Koning HJ, Steyerberg EW, Meza R. Correction: Risk prediction models for selection of lung cancer screening candidates: A retrospective validation study. Plos Medicine. 17: e1003403. PMID 32976487 DOI: 10.1371/journal.pmed.1003403  0.53
2020 Gottschlich A, Rivera-Andrade A, Bevilacqua K, Murchland AR, Isak E, Alvarez CS, Ogilvie G, Carey TE, Prince M, Dean M, Mendoza-Montano C, Meza R. Using self-collection HPV testing to increase engagement in cervical cancer screening programs in rural Guatemala: a longitudinal analysis. Bmc Public Health. 20: 1406. PMID 32933512 DOI: 10.1186/S12889-020-09478-8  0.301
2020 Tam J, Taylor GMJ, Zivin K, Warner KE, Meza R. Modeling smoking-attributable mortality among adults with major depression in the United States. Preventive Medicine. 106241. PMID 32860820 DOI: 10.1016/J.Ypmed.2020.106241  0.47
2020 Howlader N, Forjaz G, Mooradian MJ, Meza R, Kong CY, Cronin KA, Mariotto AB, Lowy DR, Feuer EJ. The Effect of Advances in Lung-Cancer Treatment on Population Mortality. The New England Journal of Medicine. 383: 640-649. PMID 32786189 DOI: 10.1056/Nejmoa1916623  0.405
2020 Levy DT, Cummings KM, Heckman BW, Li Y, Yuan Z, Smith TT, Meza R. The Public Health Gains Had Cigarette Companies Chosen to Sell Very Low Nicotine Cigarettes. Nicotine & Tobacco Research : Official Journal of the Society For Research On Nicotine and Tobacco. PMID 32710538 DOI: 10.1093/Ntr/Ntaa128  0.401
2020 Cadham CJ, Sanchez-Romero LM, Fleischer NL, Mistry R, Hirschtick JL, Meza R, Levy DT. The actual and anticipated effects of a menthol cigarette ban: a scoping review. Bmc Public Health. 20: 1055. PMID 32641026 DOI: 10.1186/S12889-020-09055-Z  0.43
2020 Criss SD, de Koning HJ, Plevritis SK, Meza R, Kong CY. Cost-Effectiveness Analysis of Lung Cancer Screening in the United States. Annals of Internal Medicine. 172: 706-707. PMID 32422089 DOI: 10.7326/L20-0072  0.446
2020 Fleischer NL, Donahoe JT, McLeod MC, Thrasher JF, Levy DT, Elliott MR, Meza R, Patrick ME. Taxation reduces smoking but may not reduce smoking disparities in youth. Tobacco Control. PMID 32269173 DOI: 10.1136/Tobaccocontrol-2019-055478  0.446
2020 Cao P, Jeon J, Levy DT, Jayasekera J, Cadham C, Mandelblatt J, Taylor K, Meza R. Potential Impact of Cessation Interventions at the Point of Lung Cancer Screening on Lung Cancer and Overall Mortality in the United States. Journal of Thoracic Oncology : Official Publication of the International Association For the Study of Lung Cancer. PMID 32160967 DOI: 10.1016/J.Jtho.2020.02.008  0.681
2020 Han SS, Chow E, Ten Haaf K, Toumazis I, Cao P, Bastani M, Tammemagi M, Jeon J, Feuer E, Meza R, Plevritis S. Disparities of national lung cancer screening guidelines in the U.S. population. Journal of the National Cancer Institute. PMID 32040195 DOI: 10.1093/Jnci/Djaa013  0.652
2020 Zavala-Arciniega L, Reynales-Shigematsu LM, Levy DT, Lau YK, Meza R, Gutiérrez-Torres DS, Arillo-Santillán E, Fleischer NL, Thrasher J. Smoking trends in Mexico, 2002-2016: before and after the ratification of the WHO's Framework Convention on Tobacco Control. Tobacco Control. PMID 32019893 DOI: 10.1136/Tobaccocontrol-2019-055153  0.44
2019 Levy D, Zavala-Arciniega L, Reynales-Shigematsu LM, Fleischer NL, Yuan Z, Li Y, Romero LMS, Lau YK, Meza R, Thrasher JF. Measuring Smoking Prevalence in a Middle Income Nation: An Examination of the 100 Cigarettes Lifetime Screen. Global Epidemiology. 1. PMID 33907731 DOI: 10.1016/j.gloepi.2019.100016  0.361
2019 Rendle KA, Burnett-Hartman AN, Neslund-Dudas C, Greenlee RT, Honda S, Elston Lafata J, Marcus PM, Cooley ME, Vachani A, Meza R, Oshiro C, Simoff MJ, Schnall M, Beaber EF, Doria-Rose VP, et al. Evaluating Lung Cancer Screening Across Diverse Healthcare Systems: A Process Model from the Lung PROSPR Consortium. Cancer Prevention Research (Philadelphia, Pa.). PMID 31871221 DOI: 10.1158/1940-6207.Capr-19-0378  0.397
2019 Gottschlich A, Ochoa P, Rivera-Andrade A, Alvarez CS, Mendoza Montano C, Camel C, Meza R. Barriers to cervical cancer screening in Guatemala: a quantitative analysis using data from the Guatemala Demographic and Health Surveys. International Journal of Public Health. PMID 31838575 DOI: 10.1007/S00038-019-01319-9  0.35
2019 Gottschlich A, Nuntadusit T, Zarins KR, Hada M, Chooson N, Bilheem S, Navakanitworakul R, Nittayaboon K, Virani S, Rozek L, Sriplung H, Meza R. Barriers to cervical cancer screening and acceptability of HPV self-testing: a cross-sectional comparison between ethnic groups in Southern Thailand. Bmj Open. 9: e031957. PMID 31685510 DOI: 10.1136/Bmjopen-2019-031957  0.344
2019 Criss SD, Cao P, Bastani M, Ten Haaf K, Chen Y, Sheehan DF, Blom EF, Toumazis I, Jeon J, de Koning HJ, Plevritis SK, Meza R, Kong CY. Cost-Effectiveness Analysis of Lung Cancer Screening in the United States: A Comparative Modeling Study. Annals of Internal Medicine. PMID 31683314 DOI: 10.7326/M19-0322  0.602
2019 Levy DT, Meza R. Tobacco 21 Laws in Europe: A Policy Whose Time Has Come. Nicotine & Tobacco Research : Official Journal of the Society For Research On Nicotine and Tobacco. PMID 31639180 DOI: 10.1093/Ntr/Ntz197  0.356
2019 Caverly TJ, Meza R. Using Risk Models to Make Lung Cancer Screening Decisions: Evidence-Based and Getting Better. Annals of Internal Medicine. PMID 31634912 DOI: 10.7326/M19-2869  0.403
2019 Salvatore M, Jeon J, Meza R. Changing trends in liver cancer incidence by race/ethnicity and sex in the US: 1992-2016. Cancer Causes & Control : Ccc. PMID 31606852 DOI: 10.1007/S10552-019-01237-4  0.557
2019 Ten Haaf K, Bastani M, Cao P, Jeon J, Toumazis I, Han SS, Plevritis SK, Blom EF, Kong CY, Tammemägi MC, Feuer EJ, Meza R, de Koning HJ. A comparative modeling analysis of risk-based lung cancer screening strategies. Journal of the National Cancer Institute. PMID 31566216 DOI: 10.1093/Jnci/Djz164  0.592
2019 Titus AR, Kalousova L, Meza R, Levy DT, Thrasher JF, Elliott MR, Lantz PM, Fleischer NL. Smoke-Free Policies and Smoking Cessation in the United States, 2003-2015. International Journal of Environmental Research and Public Health. 16. PMID 31480698 DOI: 10.3390/Ijerph16173200  0.458
2019 Cadham CJ, Jayasekera JC, Advani SM, Fallon SJ, Stephens JL, Braithwaite D, Jeon J, Cao P, Levy DT, Meza R, Taylor KL, Mandelblatt JS. Smoking cessation interventions for potential use in the lung cancer screening setting: A systematic review and meta-analysis. Lung Cancer (Amsterdam, Netherlands). 135: 205-216. PMID 31446996 DOI: 10.1016/J.Lungcan.2019.06.024  0.652
2019 Rojas-Martínez R, Escamilla-Núñez C, Meza R, Vázquez-Salas RA, Zárate-Rojas E, Lazcano-Ponce E. [Lung cancer mortality in Mexico, 1990-2016: age-period-cohort effect]. Salud Publica De Mexico. 61: 230-239. PMID 31276338 DOI: 10.21149/9962  0.397
2019 Taylor KL, Deros DE, Fallon S, Stephens J, Kim E, Lobo T, Davis KM, Luta G, Jayasekera J, Meza R, Stanton CA, Niaura RS, Abrams DB, McKee B, Howell J, et al. Study protocol for a telephone-based smoking cessation randomized controlled trial in the lung cancer screening setting: The lung screening, tobacco, and health trial. Contemporary Clinical Trials. PMID 31129371 DOI: 10.1016/J.Cct.2019.05.006  0.487
2019 Brouwer AF, Meza R, Eisenberg MC. Integrating measures of viral prevalence and seroprevalence: a mechanistic modelling approach to explaining cohort patterns of human papillomavirus in women in the USA. Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences. 374: 20180297. PMID 30955488 DOI: 10.1098/Rstb.2018.0297  0.301
2019 Tammemägi MC, Ten Haaf K, Toumazis I, Kong CY, Han SS, Jeon J, Commins J, Riley T, Meza R. Development and Validation of a Multivariable Lung Cancer Risk Prediction Model That Includes Low-Dose Computed Tomography Screening Results: A Secondary Analysis of Data From the National Lung Screening Trial. Jama Network Open. 2: e190204. PMID 30821827 DOI: 10.1001/jamanetworkopen.2019.0204  0.542
2019 Jeon J, Cao P, Luan D, Tam J, Levy D, Fleischer N, Holford T, Meza R. OA09.03 Patterns of Birth Cohort-Specific Smoking Histories by Family Income in the USA, 1982-2017 Journal of Thoracic Oncology. 14: S229. DOI: 10.1016/J.Jtho.2019.08.455  0.59
2019 Lau Y, Bhattarai H, Hung P, Jimenez-Mendoza E, Caverly T, Cote M, Arenberg D, Meza R. P2.11-35 Lung Cancer Screening Knowledge, Perceptions and Decision-Making Among African Americans Journal of Thoracic Oncology. 14: S807. DOI: 10.1016/J.Jtho.2019.08.1735  0.355
2019 Han S, Chow E, Haaf KT, Toumazis I, Bastani M, Tammemägi M, Jeon J, Feuer E, Meza R, Plevritis S. P1.11-03 Disparities and National Lung Cancer Screening Guidelines in the U.S. Population Journal of Thoracic Oncology. 14: S515-S516. DOI: 10.1016/J.Jtho.2019.08.1076  0.594
2019 Meza R, Cao P, Jeon J, Holford T. P1.10-01 Patterns of Birth Cohort-Specific Smoking Histories by Race and Ethnicity in the US, 1965-2017 Journal of Thoracic Oncology. 14: S509-S510. DOI: 10.1016/J.Jtho.2019.08.1063  0.605
2019 Levy DT, Zavala-Arciniega L, Reynales-Shigematsu LM, Fleischer NL, Yuan Z, Li Y, Sanchez-Romero LM, Lau YK, Meza R, Thrasher JF. Measuring smoking prevalence in a middle income nation: An examination of the 100 cigarettes lifetime screen Global Epidemiology. 1: 100016. DOI: 10.1016/j.gloepi.2019.100016  0.364
2018 Caverly TJ, Hayward RA, Meza R. Identifying Patients for Whom Lung Cancer Screening Is Preference-Sensitive. Annals of Internal Medicine. 169: 823. PMID 30508439 DOI: 10.7326/L18-0556  0.418
2018 Jeon J, Holford TR, Levy DT, Feuer EJ, Cao P, Tam J, Clarke L, Clarke J, Kong CY, Meza R. Smoking and Lung Cancer Mortality in the United States From 2015 to 2065: A Comparative Modeling Approach. Annals of Internal Medicine. PMID 30304504 DOI: 10.7326/M18-1250  0.675
2018 Alvarez CS, Virani S, Meza R, Rozek LS, Sriplung H, Mondul AM. Current and Future Burden of Prostate Cancer in Songkhla, Thailand: Analysis of Incidence and Mortality Trends From 1990 to 2030. Journal of Global Oncology. 1-11. PMID 30241231 DOI: 10.1200/Jgo.17.00128  0.326
2018 Chang JT, Jeon J, Sriplung H, Yeesoonsang S, Bilheem S, Rozek L, Chitapanarux I, Pongnikorn D, Daoprasert K, Vatanasapt P, Suwanrungruang K, Meza R. Temporal Trends and Geographic Patterns of Lung Cancer Incidence by Histology in Thailand, 1990 to 2014. Journal of Global Oncology. 1-29. PMID 30192698 DOI: 10.1200/Jgo.18.00013  0.596
2018 Bidwell SS, Peterson CC, Demanelis K, Zarins K, Meza R, Sriplung H, Wiangnon S, Chotsampancharoen T, Chitapanarux I, Pongnikorn D, Daoprasert K, Suwanrungruang K, Chansaard W, Rozek LS. Childhood cancer incidence and survival in Thailand: A comprehensive population-based registry analysis, 1990-2011. Pediatric Blood & Cancer. e27428. PMID 30168253 DOI: 10.1002/Pbc.27428  0.362
2018 Lau YK, Tam J, Fleischer NL, Meza R. Neighbourhood deprivation, smoking, and race in South Africa: A cross-sectional analysis. Preventive Medicine Reports. 11: 202-208. PMID 29998052 DOI: 10.1016/J.Pmedr.2018.07.001  0.443
2018 Brouwer AF, Eisenberg MC, Meza R. Case Studies of Gastric, Lung, and Oral Cancer Connect Etiologic Agent Prevalence to Cancer Incidence. Cancer Research. 78: 3386-3396. PMID 29907681 DOI: 10.1158/0008-5472.Can-17-3467  0.428
2018 Caverly TJ, Cao P, Hayward RA, Meza R. Identifying Patients for Whom Lung Cancer Screening is Preference-Sensitive: A Microsimulation Study. Annals of Internal Medicine. PMID 29809244 DOI: 10.7326/M17-2561  0.354
2018 Tam J, Levy DT, Jeon J, Clarke J, Gilkeson S, Hall T, Feuer EJ, Holford TR, Meza R. Projecting the effects of tobacco control policies in the USA through microsimulation: a study protocol. Bmj Open. 8: e019169. PMID 29574440 DOI: 10.1136/Bmjopen-2017-019169  0.599
2018 Tam J, Levy D, Meza R. The Tobacco Control Policy (TCP) Tool: a web-based interface to simulate the effects of tobacco policies in the United States Tobacco Induced Diseases. 16. DOI: 10.18332/Tid/84717  0.321
2018 Lau YK, Cao P, Jeon J, Meza R. Age, period and cohort trends in smoking in Mexico, 2000-2016 Tobacco Induced Diseases. 16. DOI: 10.18332/Tid/84285  0.621
2018 Cao P, Jeon J, Tam J, Holford TR, Fleischer NL, Meza R. Smoking disparities by level of educational attainment in the United States, 1966 to 2015 Tobacco Induced Diseases. 16. DOI: 10.18332/Tid/84014  0.574
2018 Tam J, Taylor G, Zivin K, Meza R. Modeling smoking and depression comorbidity in the U.S Tobacco Induced Diseases. 16. DOI: 10.18332/Tid/83864  0.376
2018 Jeon J, Meza R, Rozek L, Sriplung H. Trends of Colorectal Cancer Incidence in Thailand by Age, Gender, and Region Journal of Global Oncology. 4: 11s-11s. DOI: 10.1200/Jgo.18.73800  0.552
2018 Jeon J, Holford T, Levy D, Feuer E, Cao P, Tam J, Clarke L, Clarke J, Kong C, Meza R. OA09.05 Potential Reduction in Lung Cancer Mortality in the US from 2015-2065: A Comparative Modeling Approach Journal of Thoracic Oncology. 13: S341-S342. DOI: 10.1016/J.Jtho.2018.08.284  0.584
2018 Caverly T, Cao P, Hayward R, Meza R. P2.11-15 Identifying Patients for Whom Lung Cancer Screening is Preference-Sensitive: A Microsimulation Study Journal of Thoracic Oncology. 13: S784. DOI: 10.1016/J.Jtho.2018.08.1362  0.387
2017 Han SS, Ten Haaf K, Hazelton WD, Jeon J, Meza R, Kong CY, Feuer EJ, de Koning HJ, Plevritis SK. Re: Think Before You Leap. International Journal of Cancer. PMID 29194597 DOI: 10.1002/Ijc.31183  0.465
2017 Chang JT, Levy DT, Meza R. Examining the Transitions between Cigarette and Smokeless Tobacco Product Use in the United States Using the 2002-2003 and 2010-2011 Longitudinal Cohorts. Nicotine & Tobacco Research : Official Journal of the Society For Research On Nicotine and Tobacco. PMID 29126271 DOI: 10.1093/Ntr/Ntx251  0.425
2017 Gottschlich A, Rivera-Andrade A, Grajeda E, Alvarez C, Mendoza Montano C, Meza R. Acceptability of Human Papillomavirus Self-Sampling for Cervical Cancer Screening in an Indigenous Community in Guatemala. Journal of Global Oncology. 3: 444-454. PMID 29094082 DOI: 10.1200/Jgo.2016.005629  0.339
2017 Levy DT, Borland R, Lindblom EN, Goniewicz ML, Meza R, Holford TR, Yuan Z, Luo Y, O'Connor RJ, Niaura R, Abrams DB. Potential deaths averted in USA by replacing cigarettes with e-cigarettes. Tobacco Control. PMID 28970328 DOI: 10.1136/Tobaccocontrol-2017-053759  0.421
2017 Levy DT, Borland R, Lindblom EN, Goniewicz ML, Meza R, Holford TR, Yuan Z, Luo Y, O'Connor RJ, Niaura R, Abrams DB. Potential deaths averted in USA by replacing cigarettes with e-cigarettes. Tobacco Control. PMID 28970328 DOI: 10.1136/tobaccocontrol-2017-053759  0.308
2017 Ten Haaf K, Jeon J, Tammemägi MC, Han SS, Kong CY, Plevritis SK, Feuer EJ, de Koning HJ, Steyerberg EW, Meza R. Risk prediction models for selection of lung cancer screening candidates: A retrospective validation study. Plos Medicine. 14: e1002277. PMID 28376113 DOI: 10.1371/Journal.Pmed.1002277  0.687
2017 Brouwer AF, Meza R, Eisenberg MC. Parameter estimation for multistage clonal expansion models from cancer incidence data: A practical identifiability analysis. Plos Computational Biology. 13: e1005431. PMID 28288156 DOI: 10.1371/Journal.Pcbi.1005431  0.36
2017 Han SS, Ten Haaf K, Hazelton WD, Munshi VN, Jeon J, Erdogan SA, Johanson C, McMahon PM, Meza R, Kong CY, Feuer EJ, de Koning HJ, Plevritis SK. The impact of overdiagnosis on the selection of efficient lung cancer screening strategies. International Journal of Cancer. PMID 28073150 DOI: 10.1002/Ijc.30602  0.598
2017 Gottschlich A, Murchland A, Bevilacqua K, Pineda A, Rivera-Andrade A, Alvarez C, Ogilvie G, Mendoza-Montano C, Meza R. Abstract C64: Use of HPV self-sampling to increase screening for cervical cancer in indigenous and rural communities in Guatemala Cancer Epidemiology, Biomarkers & Prevention. 26. DOI: 10.1158/1538-7755.Disp16-C64  0.306
2017 Cao P, Caverly T, Hayward R, Meza R. Abstract PR16: Effect of cancer risk and patient preferences on net benefit of lung cancer screening: A personalized lung cancer screening model Cancer Epidemiology and Prevention Biomarkers. 26. DOI: 10.1158/1538-7755.Carisk16-Pr16  0.448
2016 Gaber C, Meza R, Ruterbusch JJ, Cote ML. Endometrial Cancer Trends by Race and Histology in the USA: Projecting the Number of New Cases from 2015 to 2040. Journal of Racial and Ethnic Health Disparities. PMID 27753051 DOI: 10.1007/S40615-016-0292-2  0.335
2016 Crothers K, Kross E, Reisch LM, Shahrir SF, Slatore C, Zeliadt SB, Triplette M, Meza R, Elmore JG. Patients' Attitudes Regarding Lung Cancer Screening and Decision Aids: A Survey and Focus Group Study. Annals of the American Thoracic Society. PMID 27652509 DOI: 10.1513/Annalsats.201604-289Oc  0.383
2016 Levy DT, Borland R, Villanti AC, Niaura R, Yuan Z, Zhang Y, Meza R, Holford TR, Fong GT, Cummings KM, Abrams DB. The Application of a Decision-Theoretic Model to Estimate the Public Health Impact of Vaporized Nicotine Product Initiation in the United States. Nicotine & Tobacco Research : Official Journal of the Society For Research On Nicotine and Tobacco. PMID 27613952 DOI: 10.1093/Ntr/Ntw158  0.439
2016 Tam J, Warner KE, Meza R. Smoking and the Reduced Life Expectancy of Individuals With Serious Mental Illness. American Journal of Preventive Medicine. PMID 27522471 DOI: 10.1016/J.Amepre.2016.06.007  0.387
2016 Mitro SD, Rozek LS, Vatanasapt P, Suwanrungruang K, Chitapanarux I, Srisukho S, Sriplung H, Meza R. Iodine deficiency and thyroid cancer trends in three regions of Thailand, 1990-2009. Cancer Epidemiology. 43: 92-99. PMID 27420631 DOI: 10.1016/J.Canep.2016.07.002  0.314
2016 Mantey J, Ruterbusch J, Meza R, Schwartz K. Cancer incidence trends using American Community Survey estimates are not consistent with SEER for small populations. Cancer Epidemiology. 43: 87-91. PMID 27420630 DOI: 10.1016/J.Canep.2016.06.014  0.311
2016 Cherng ST, Tam J, Christine PJ, Meza R. Modeling the Effects of E-Cigarettes on Smoking Behavior: Implications for Future Adult Smoking Prevalence. Epidemiology (Cambridge, Mass.). PMID 27093020 DOI: 10.1097/Ede.0000000000000497  0.438
2016 Chang JT, Levy DT, Meza R. Trends and Factors related to Smokeless Tobacco Use in the United States. Nicotine & Tobacco Research : Official Journal of the Society For Research On Nicotine and Tobacco. PMID 26995793 DOI: 10.1093/Ntr/Ntw090  0.392
2016 Levy DT, Huang AT, Havumaki JS, Meza R. The role of public policies in reducing smoking prevalence: results from the Michigan SimSmoke tobacco policy simulation model. Cancer Causes & Control : Ccc. PMID 26983616 DOI: 10.1007/S10552-016-0735-4  0.414
2016 Holford TR, Levy DT, Meza R. Comparison of Smoking History Patterns Among African American and White Cohorts in the United States Born 1890 to 1990. Nicotine & Tobacco Research : Official Journal of the Society For Research On Nicotine and Tobacco. 18: S16-29. PMID 26980861 DOI: 10.1093/Ntr/Ntv274  0.425
2016 Fleischer NL, Thrasher JF, Reynales-Shigematsu LM, Cummings KM, Meza R, Zhang Y, Levy DT. Mexico SimSmoke: how changes in tobacco control policies would impact smoking prevalence and smoking attributable deaths in Mexico. Global Public Health. 1-16. PMID 26837721 DOI: 10.1080/17441692.2015.1123749  0.461
2016 Alvarez C, Virani S, Meza R, Rozek L, Sriplung H, Mondul AM. Abstract 5210: Incidence and mortality trends of prostate cancer in southern Thailand Cancer Research. 76: 5210-5210. DOI: 10.1158/1538-7445.Am2016-5210  0.337
2016 Gottschlich A, Meza R, Rivera-Andrade A, Grajeda E, Alvarez C, Montano CM. Abstract 2584: HPV prevalence and acceptability of HPV self-sampling for cervical cancer screening in the community of Santiago Atitlan, Guatemala Cancer Research. 76: 2584-2584. DOI: 10.1158/1538-7445.Am2016-2584  0.319
2016 Demanelis K, Sriplung H, Meza R, Wiangnon S, Rozek LS, Scheurer ME, Lupo PJ. Abstract 1784: Disparities in pediatric leukemia incidence and survival: a population-based cancer registry analysis comparing Thailand and the United States Cancer Research. 76: 1784-1784. DOI: 10.1158/1538-7445.Am2016-1784  0.307
2015 Reynales-Shigematsu LM, Fleischer NL, Thrasher JF, Zhang Y, Meza R, Cummings KM, Levy DT. Effects of tobacco control policies on smoking prevalence and tobacco-attributable deaths in Mexico: the SimSmoke model. Revista Panamericana De Salud PúBlica = Pan American Journal of Public Health. 38: 316-25. PMID 26758223  0.346
2015 Levy DT, Meza R, Zhang Y, Holford TR. Gauging the Effect of U.S. Tobacco Control Policies From 1965 Through 2014 Using SimSmoke. American Journal of Preventive Medicine. PMID 26673484 DOI: 10.1016/J.Amepre.2015.10.001  0.339
2015 Lau YK, Caverly TJ, Cao P, Cherng ST, West M, Gaber C, Arenberg D, Meza R. Evaluation of a Personalized, Web-Based Decision Aid for Lung Cancer Screening. American Journal of Preventive Medicine. PMID 26456873 DOI: 10.1016/J.Amepre.2015.07.027  0.383
2015 Meza R, Chang JT. Multistage carcinogenesis and the incidence of thyroid cancer in the US by sex, race, stage and histology. Bmc Public Health. 15: 789. PMID 26282269 DOI: 10.1186/S12889-015-2108-4  0.332
2015 Meza R, Meernik C, Jeon J, Cote ML. Lung cancer incidence trends by gender, race and histology in the United States, 1973-2010. Plos One. 10: e0121323. PMID 25822850 DOI: 10.1371/Journal.Pone.0121323  0.582
2015 Jeon J, Meza R, Hazelton WD, Renehan AG, Luebeck EG. Incremental benefits of screening colonoscopy over sigmoidoscopy in average-risk populations: a model-driven analysis. Cancer Causes & Control : Ccc. 26: 859-70. PMID 25783458 DOI: 10.1007/S10552-015-0559-7  0.575
2014 Lau YK, Caverly TJ, Cherng ST, Cao P, West M, Arenberg D, Meza R. Development and validation of a personalized, web-based decision aid for lung cancer screening using mixed methods: a study protocol. Jmir Research Protocols. 3: e78. PMID 25532218 DOI: 10.2196/Resprot.4039  0.413
2014 McMahon PM, Meza R, Plevritis SK, Black WC, Tammemagi CM, Erdogan A, ten Haaf K, Hazelton W, Holford TR, Jeon J, Clarke L, Kong CY, Choi SE, Munshi VN, Han SS, et al. Comparing benefits from many possible computed tomography lung cancer screening programs: extrapolating from the National Lung Screening Trial using comparative modeling. Plos One. 9: e99978. PMID 24979231 DOI: 10.1371/Journal.Pone.0099978  0.732
2014 Bergmans R, Soliman AS, Ruterbusch J, Meza R, Hirko K, Graff J, Schwartz K. Cancer incidence among Arab Americans in California, Detroit, and New Jersey SEER registries. American Journal of Public Health. 104: e83-91. PMID 24825237 DOI: 10.2105/Ajph.2014.301954  0.335
2014 Virani S, Sriplung H, Rozek LS, Meza R. Escalating burden of breast cancer in southern Thailand: analysis of 1990-2010 incidence and prediction of future trends. Cancer Epidemiology. 38: 235-43. PMID 24767872 DOI: 10.1016/J.Canep.2014.03.003  0.337
2014 Kong CY, Kroep S, Curtius K, Hazelton WD, Jeon J, Meza R, Heberle CR, Miller MC, Choi SE, Lansdorp-Vogelaar I, van Ballegooijen M, Feuer EJ, Inadomi JM, Hur C, Luebeck EG. Exploring the recent trend in esophageal adenocarcinoma incidence and mortality using comparative simulation modeling. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 23: 997-1006. PMID 24692500 DOI: 10.1158/1055-9965.Epi-13-1233  0.522
2014 Roen EL, Copeland GE, Pinagtore NL, Meza R, Soliman AS. Disparities of cancer incidence in Michigan's American Indians: spotlight on breast cancer. Cancer. 120: 1847-53. PMID 24676851 DOI: 10.1002/Cncr.28589  0.366
2014 Meza R, ten Haaf K, Kong CY, Erdogan A, Black WC, Tammemagi MC, Choi SE, Jeon J, Han SS, Munshi V, van Rosmalen J, Pinsky P, McMahon PM, de Koning HJ, Feuer EJ, et al. Comparative analysis of 5 lung cancer natural history and screening models that reproduce outcomes of the NLST and PLCO trials. Cancer. 120: 1713-24. PMID 24577803 DOI: 10.1002/Cncr.28623  0.622
2014 Holford TR, Levy DT, McKay LA, Clarke L, Racine B, Meza R, Land S, Jeon J, Feuer EJ. Patterns of birth cohort-specific smoking histories, 1965-2009. American Journal of Preventive Medicine. 46: e31-7. PMID 24439359 DOI: 10.1016/J.Amepre.2013.10.022  0.648
2014 Holford TR, Meza R, Warner KE, Meernik C, Jeon J, Moolgavkar SH, Levy DT. Tobacco control and the reduction in smoking-related premature deaths in the United States, 1964-2012. Jama. 311: 164-71. PMID 24399555 DOI: 10.1016/J.Jvs.2014.02.030  0.725
2014 de Koning HJ, Meza R, Plevritis SK, ten Haaf K, Munshi VN, Jeon J, Erdogan SA, Kong CY, Han SS, van Rosmalen J, Choi SE, Pinsky PF, Berrington de Gonzalez A, Berg CD, Black WC, et al. Benefits and harms of computed tomography lung cancer screening strategies: a comparative modeling study for the U.S. Preventive Services Task Force. Annals of Internal Medicine. 160: 311-20. PMID 24379002 DOI: 10.7326/M13-2316  0.666
2012 Hazelton WD, Jeon J, Meza R, Moolgavkar SH. Chapter 8: The FHCRC lung cancer model. Risk Analysis : An Official Publication of the Society For Risk Analysis. 32: S99-S116. PMID 22882896 DOI: 10.1111/J.1539-6924.2011.01681.X  0.755
2012 McCarthy WJ, Meza R, Jeon J, Moolgavkar SH. Chapter 6: Lung cancer in never smokers: epidemiology and risk prediction models. Risk Analysis : An Official Publication of the Society For Risk Analysis. 32: S69-84. PMID 22882894 DOI: 10.1111/J.1539-6924.2012.01768.X  0.757
2012 Jeon J, Meza R, Krapcho M, Clarke LD, Byrne J, Levy DT. Chapter 5: Actual and counterfactual smoking prevalence rates in the U.S. population via microsimulation. Risk Analysis : An Official Publication of the Society For Risk Analysis. 32: S51-68. PMID 22882892 DOI: 10.1111/J.1539-6924.2011.01775.X  0.665
2012 Moolgavkar SH, Holford TR, Levy DT, Kong CY, Foy M, Clarke L, Jeon J, Hazelton WD, Meza R, Schultz F, McCarthy W, Boer R, Gorlova O, Gazelle GS, Kimmel M, et al. Impact of reduced tobacco smoking on lung cancer mortality in the United States during 1975-2000. Journal of the National Cancer Institute. 104: 541-8. PMID 22423009 DOI: 10.1093/Jnci/Djs136  0.758
2012 Burkhart R, Ruterbusch J, Soliman A, Meza R, Hirko K, Graff J, Schwartz K. Abstract A68: Cancer incidence among Arab Americans in California, Detroit, and New Jersey SEER registries, 2000. Cancer Epidemiology, Biomarkers & Prevention. 21. DOI: 10.1158/1055-9965.Disp12-A68  0.376
2011 Dewanji A, Jeon J, Meza R, Luebeck EG. Number and size distribution of colorectal adenomas under the multistage clonal expansion model of cancer. Plos Computational Biology. 7: e1002213. PMID 22022253 DOI: 10.1371/Journal.Pcbi.1002213  0.559
2010 Meza R, Jeon J, Renehan AG, Luebeck EG. Colorectal cancer incidence trends in the United States and United kingdom: evidence of right- to left-sided biological gradients with implications for screening. Cancer Research. 70: 5419-29. PMID 20530677 DOI: 10.1158/0008-5472.Can-09-4417  0.553
2010 Meza R, Jeon J, Moolgavkar SH. Quantitative Cancer Risk Assessment of Nongenotoxic Carcinogens Cancer Risk Assessment: Chemical Carcinogenesis, Hazard Evaluation, and Risk Quantification. 636-658. DOI: 10.1002/9780470622728.ch25  0.644
2009 Moolgavkar SH, Meza R, Turim J. Pleural and peritoneal mesotheliomas in SEER: age effects and temporal trends, 1973-2005. Cancer Causes & Control : Ccc. 20: 935-44. PMID 19294523 DOI: 10.1007/S10552-009-9328-9  0.545
2008 Meza R, Jeon J, Moolgavkar SH, Luebeck EG. Age-specific incidence of cancer: Phases, transitions, and biological implications. Proceedings of the National Academy of Sciences of the United States of America. 105: 16284-9. PMID 18936480 DOI: 10.1073/Pnas.0801151105  0.642
2008 Jeon J, Meza R, Moolgavkar SH, Luebeck EG. Evaluation of screening strategies for pre-malignant lesions using a biomathematical approach. Mathematical Biosciences. 213: 56-70. PMID 18374369 DOI: 10.1016/J.Mbs.2008.02.006  0.684
2008 Meza R, Hazelton WD, Colditz GA, Moolgavkar SH. Analysis of lung cancer incidence in the Nurses' Health and the Health Professionals' Follow-Up Studies using a multistage carcinogenesis model. Cancer Causes & Control : Ccc. 19: 317-28. PMID 18058248 DOI: 10.1007/S10552-007-9094-5  0.693
2005 Meza R, Luebeck EG, Moolgavkar SH. Gestational mutations and carcinogenesis. Mathematical Biosciences. 197: 188-210. PMID 16087198 DOI: 10.1016/J.Mbs.2005.06.003  0.55
Show low-probability matches.